Researchers examine link between long-term use of blood pressure drugs and breast cancer risk
Always a concern. Risk benefit
Related Articles
AANA Annual Meeting
The Arthroscopy Association of North America’s Annual Meeting is the world’s largest arthroscopy-focused event of the year. Join AANA and colleagues from around the world…
Cretostimogene Grenadenorepvec Therapy Aims to Fill an Unmet Need in the Bladder Cancer Armamentarium – Robert Svatek
Zach Klaassen and Rob Svatek explore the potential of cretostimogene, a novel medication for non-muscle invasive bladder cancer. Dr. Svatek describes cretostimogene as an oncolytic…
Sleep Apnea and Insomnia Are Highly Prevalent and Linked to Disease Worsening in Neuropsychiatric Disorders
Large cohort study suggests a clear need for routine screening and treatment of sleep disorders in neurological and psychiatric populations. Large cohort study shows a…
Efficacy and safety of eliapixant in diabetic neuropathic… : PAIN
ype 1 or type 2 diabetes mellitus with painful distal symmetric sensorimotor neuropathy of >6 months’ duration and neuropathic pain were enrolled and randomized 1:1…
Meeting Community Need: First, an ASC, Then the New Hospital Comes Later
“An ambulatory surgery center will help us take the ambulatory volume out of the hospital, which will then give us capacity to grow inpatient procedures,”…
Virtual acute-care program makes patients feel right at home
Kaiser Permanente’s hospital-at-home effort has readmission rates that are lower than the national average—with no signs of slowing down.
Brain transcriptomic, metabolic and mitohormesis properties associated with N-propargylglycine treatment: A prevention strategy against neurodegeneration
There is an urgent need for new or repurposed therapeutics that protect against or significantly delay the clinical progression of neurodegenerative d…
Payer Roundup—Elevance Health acquires New York-based MCO; Sentara Health Plans under investigation
Below is a roundup of payer-centric news for the week of April 15, 2024. | This week, Elevance Health acquires its competitor in New York,…
Treatment Relieves Chronic Lyme Disease’s Neurological Symptoms – Neuroscience News
Fibroblast growth factor receptor inhibitors, commonly used in cancer treatment, could effectively reduce neurological symptoms in patients with post-treatment Lyme disease syndrome.
Survival rates, outcomes favorable for those given ECMO with neurosurgical intervention
DENVER —Extracorporeal membrane oxygenation therapy led to favorable survival and neurologic outcomes for patients who required neurosurgical intervention, according to a poster at the American…
